KiWu-B: Effects of a Fasting Mimicking Diet on Sperm Quality

Sponsor
Charite University, Berlin, Germany (Other)
Overall Status
Recruiting
CT.gov ID
NCT04908774
Collaborator
Karl and Veronica Carstens Foundation (Other)
42
1
2
18.2
2.3

Study Details

Study Description

Brief Summary

This study investigates the effect of repetitive cycles of a Fasting Mimicking Diet (3x5 days in six months) on sperm quality in men

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Fasting Mimicking Diet
N/A

Detailed Description

This 2-arm, randomized, controlled exploratory clinical trial aims to explore fasting as a novel supportive treatment in male infertility due to reduced sperm quality according to WHO5-criteria. The participants will be randomized in two groups. The intervention group follows a regime of a periodic fasting mimicking diet (3x5 days in six months, every 6-8 weeks, accompanied via a mobile application), whereas the patients on the waiting list continue their normal diet. Spermiograms are taken about every 2 months following the WHO-5 criteria. In addition, qualitative interviews will be conducted including individual and focus group interviews with a subgroup of participants.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
42 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This explorative study is conducted in form of a randomized, controlled trial design with a fasting intervention and a waiting list, which continues the usual diet.This explorative study is conducted in form of a randomized, controlled trial design with a fasting intervention and a waiting list, which continues the usual diet.
Masking:
Single (Outcomes Assessor)
Masking Description:
It is not possible to mask a fasting intervention for the participant or the study personel. Therefore only outcome assessors are masked.
Primary Purpose:
Treatment
Official Title:
Effects of Repetitive Cycles of a Fasting Mimicking Diet on Sperm Quality in Men Between 18 and 60 With Reduced Sperm Quality According to the WHO-5 Criteria.
Actual Study Start Date :
May 25, 2021
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fasting Mimicking Diet Group

The intervention group follows a fasting mimicking diet for 5 days every 6-8 weeks (a total of 3 times in 5 months).

Behavioral: Fasting Mimicking Diet
The mobile application "Salufast" provides standardised fasting packages for 5 days of approx. 500 kcal and accompanies the participants during all fasting days.
Other Names:
  • Fasting
  • Dietary Intervention
  • No Intervention: Control Group

    This group maintains their individual diet during the whole time of the study. After 6 months they are offered a fasting intervention.

    Outcome Measures

    Primary Outcome Measures

    1. Change in Total sperm motility [change from baseline to 6 months after baseline]

      WHO-5 spermiogram parameter to measure sperm quality

    2. Qualitative interview analysis [up to 48 weeks after fasting intervention]

      individual and focus group interviews

    Secondary Outcome Measures

    1. spermiogram following the WHO-5 criteria [baseline and approx. every 2 months over the course of a year (12 months)]

      WHO-5 measurement of sperm quality

    2. quality of life according to the WHO-5 questionnaire [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      WHO-5 questionnaire, validated questionnaire to examine quality of life

    3. mindfulness [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      MAAS-questionnaire, validated questionnaire to examine mindfulness

    4. anxiety and depression [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      HADS-questionnaire, validated questionnaire to examine anxiety and depression

    5. current mood [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      ASTS-questionnaire, validated questionnaire to examine current mood

    6. experienced stress [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      Cohen-stress scale, validated questionnaire to examine experienced stress

    7. physical fitness [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      questionnaire to examine physical fitness

    8. Changes in diet [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      questionnaire to examine diet

    9. quality of relationship [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      questionnaire to examine the relationship between the two partners desiring to have a child

    10. psychological stress caused by the unfulfilled desire to have children [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      questionnaire to examine the psychological stress caused by the unfulfilled desire to have children

    11. gratitude [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      validated questionnaire to examine gratitude

    12. self-efficacy [baseline, after one week, after 8 (±2) weeks, after 12 (±2) weeks, after 17 (±2) weeks, after 26 (±2) weeks and after 52 (±2) weeks]

      ASKU, validated questionnaire to examine self-efficacy

    Other Outcome Measures

    1. liver sonography [up to 14 days before, during and up to 14 days after a fasting intervention]

      sonography in a subgroup

    2. reported pregnancy of female partner [up to 12 months after baseline]

      questionnaire

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Men aged between 18 and 60 years

    • Unfulfilled desire to have a child > 1 year

    • reduced sperm quality (proven via spermiogram according tho WHO-5 criteria)

    • informed consent

    • 20 kg/m² <= BMI <= 35 kg/m²

    Exclusion Criteria:
    • No sufficient communication possible

    • severely impairing cognitive illness

    • serious mental illness

    • Patients with anatomical/organic damage of reproductive organs

    • Eating disorders in the medical history

    • Serious internal diseases

    • Lack of internet access

    • No consent to randomisation

    • Participation in other studies

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hochschulambulanz für Naturheilkunde der Charité-Universitätsmedizin Berlin Berlin Germany 14109

    Sponsors and Collaborators

    • Charite University, Berlin, Germany
    • Karl and Veronica Carstens Foundation

    Investigators

    • Principal Investigator: Andreas Michalsen, Prof. Dr., Charite University, Berlin, Germany

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Andreas Michalsen, Prof. Dr. med., Charite University, Berlin, Germany
    ClinicalTrials.gov Identifier:
    NCT04908774
    Other Study ID Numbers:
    • KiWu-B
    First Posted:
    Jun 1, 2021
    Last Update Posted:
    Jun 1, 2021
    Last Verified:
    May 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Andreas Michalsen, Prof. Dr. med., Charite University, Berlin, Germany
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 1, 2021